1	Outcomes	Outcome	B-NP	NNS	O	0	ROOT
2	of	of	B-PP	IN	O	1	NMOD
3	emergency	emergency	B-NP	NN	O	4	NMOD
4	colectomy	colectomy	I-NP	NN	O	2	PMOD
5	for	for	B-PP	IN	O	4	NMOD
6	fulminant	fulminant	B-NP	JJ	O	9	NMOD
7	Clostridium	Clostridium	I-NP	NN	O	9	NMOD
8	difficile	difficile	I-NP	JJ	O	9	NMOD
9	colitis	colitis	I-NP	NN	O	5	PMOD
10	.	.	O	.	O	1	P

1	Clostridium	Clostridium	B-NP	NN	O	2	NMOD
2	difficile	difficile	I-NP	NN	O	3	SUB
3	has	have	B-VP	VBZ	O	0	ROOT
4	become	become	I-VP	VBN	O	3	VC
5	increasingly	increasingly	B-ADVP	RB	O	4	VMOD
6	a	a	B-NP	DT	O	8	NMOD
7	common	common	I-NP	JJ	O	8	NMOD
8	cause	cause	I-NP	NN	O	4	PRD
9	of	of	B-PP	IN	O	8	NMOD
10	nosocomial	nosocomial	B-NP	JJ	O	11	NMOD
11	infection	infection	I-NP	NN	O	9	PMOD
12	with	with	B-PP	IN	O	8	NMOD
13	increasing	increase	B-VP	VBG	O	12	PMOD
14	antibiotic	antibiotic	B-NP	JJ	O	15	NMOD
15	usage	usage	I-NP	NN	O	13	OBJ
16	.	.	O	.	O	3	P

1	Recently	Recently	B-ADVP	RB	O	3	VMOD
2	there	there	B-NP	EX	O	3	SUB
3	has	have	B-VP	VBZ	O	0	ROOT
4	been	be	I-VP	VBN	O	3	VC
5	an	an	B-NP	DT	O	6	NMOD
6	increase	increase	I-NP	NN	O	4	PRD
7	in	in	B-PP	IN	O	6	NMOD
8	the	the	B-NP	DT	O	9	NMOD
9	incidence	incidence	I-NP	NN	O	7	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	patients	patient	B-NP	NNS	O	10	PMOD
12	undergoing	undergo	B-VP	VBG	O	11	NMOD
13	colectomy	colectomy	B-NP	NN	O	12	OBJ
14	for	for	B-PP	IN	O	11	NMOD
15	fulminant	fulminant	B-NP	JJ	O	18	NMOD
16	C.	C.	I-NP	FW	O	18	NMOD
17	difficile	difficile	I-NP	JJ	O	18	NMOD
18	colitis	colitis	I-NP	NN	O	14	PMOD
19	(	(	O	(	O	21	DEP
20	FCDC	FCDC	B-NP	NN	B-protein	21	DEP
21	)	)	O	)	O	18	NMOD
22	.	.	O	.	O	3	P

1	Early	Early	B-NP	RB	O	2	AMOD
2	surgical	surgical	I-NP	JJ	O	3	NMOD
3	consultation	consultation	I-NP	NN	O	4	SUB
4	is	be	B-VP	VBZ	O	0	ROOT
5	necessary	necessary	B-ADJP	JJ	O	4	PRD
6	to	to	B-VP	TO	O	7	VMOD
7	avoid	avoid	I-VP	VB	O	5	AMOD
8	delay	delay	B-NP	NN	O	7	OBJ
9	in	in	B-PP	IN	O	8	NMOD
10	diagnosis	diagnosis	B-NP	NN	O	9	PMOD
11	.	.	O	.	O	4	P

1	We	We	B-NP	PRP	O	2	SUB
2	present	present	B-VP	VBP	O	0	ROOT
3	a	a	B-NP	DT	O	5	NMOD
4	retrospective	retrospective	I-NP	JJ	O	5	NMOD
5	review	review	I-NP	NN	O	2	OBJ
6	of	of	B-PP	IN	O	5	NMOD
7	the	the	B-NP	DT	O	8	NMOD
8	outcomes	outcome	I-NP	NNS	O	6	PMOD
9	of	of	B-PP	IN	O	8	NMOD
10	colectomies	colectomy	B-NP	NNS	O	9	PMOD
11	for	for	B-PP	IN	O	10	NMOD
12	FCDC	FCDC	B-NP	NN	B-cell_type	11	PMOD
13	at	at	B-PP	IN	O	2	VMOD
14	our	our	B-NP	PRP$	O	18	NMOD
15	large	large	I-NP	JJ	O	18	NMOD
16	district	district	I-NP	NN	O	18	NMOD
17	general	general	I-NP	JJ	O	18	NMOD
18	hospital	hospital	I-NP	NN	O	13	PMOD
19	.	.	O	.	O	2	P

1	Over	Over	B-PP	IN	O	21	VMOD
2	a	a	B-NP	DT	O	6	NMOD
3	twenty	twenty	I-NP	CD	O	4	AMOD
4	one	one	I-NP	CD	O	6	NMOD
5	month	month	I-NP	NN	O	6	NMOD
6	period	period	I-NP	NN	O	1	PMOD
7	,	,	O	,	O	21	P
8	from	from	B-PP	IN	O	21	VMOD
9	January	January	B-NP	NNP	O	8	PMOD
10	2007	2007	I-NP	CD	O	9	NMOD
11	to	to	B-PP	TO	O	8	PMOD
12	September	September	B-NP	NNP	O	11	PMOD
13	2009	2009	I-NP	CD	O	12	NMOD
14	,	,	O	,	O	21	P
15	a	a	B-NP	DT	O	17	NMOD
16	total	total	I-NP	JJ	O	17	NMOD
17	number	number	I-NP	NN	O	21	SUB
18	of	of	B-PP	IN	O	17	NMOD
19	20	20	B-NP	CD	O	20	NMOD
20	patients	patient	I-NP	NNS	O	18	PMOD
21	underwent	undergo	B-VP	VBD	O	0	ROOT
22	exploratory	exploratory	B-NP	JJ	O	23	NMOD
23	laparotomy	laparotomy	I-NP	NN	O	21	OBJ
24	for	for	B-PP	IN	O	23	NMOD
25	FCDC	FCDC	B-NP	NN	B-cell_type	24	PMOD
26	.	.	O	.	O	21	P

1	A	A	B-NP	DT	O	3	NMOD
2	retrospective	retrospective	I-NP	JJ	O	3	NMOD
3	analysis	analysis	I-NP	NN	O	10	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	patients	patient	B-NP	NNS	O	6	NMOD
6	'	'	B-NP	POS	O	8	NMOD
7	case	case	I-NP	NN	O	8	NMOD
8	notes	note	I-NP	NNS	O	4	PMOD
9	,	,	O	,	O	3	P
10	was	be	B-VP	VBD	O	0	ROOT
11	carried	carry	I-VP	VBN	O	10	VC
12	out	out	B-PRT	RP	O	11	VMOD
13	retrieving	retrieve	B-VP	VBG	O	11	VMOD
14	all	all	B-NP	DT	O	15	NMOD
15	relevant	relevant	I-NP	JJ	O	13	OBJ
16	.	.	O	.	O	10	P

1	Data	Datum	B-NP	NNS	O	8	SUB
2	on	on	B-PP	IN	O	1	NMOD
3	haematology	haematology	B-NP	NN	O	7	NMOD
4	,	,	I-NP	,	O	7	P
5	biochemistry	biochemistry	I-NP	NN	O	7	NMOD
6	and	and	I-NP	CC	O	7	NMOD
7	imaging	imaging	I-NP	NN	O	2	PMOD
8	were	be	B-VP	VBD	O	0	ROOT
9	extracted	extract	I-VP	VBN	O	8	VC
10	from	from	B-PP	IN	O	9	VMOD
11	the	the	B-NP	DT	O	16	NMOD
12	trust	trust	I-NP	NN	B-protein	16	NMOD
13	's	's	B-NP	POS	I-protein	16	NMOD
14	on-line	on-line	I-NP	JJ	I-protein	16	NMOD
15	clinical	clinical	I-NP	JJ	I-protein	16	NMOD
16	databases	database	I-NP	NNS	I-protein	10	PMOD
17	.	.	O	.	O	8	P

1	A	A	B-NP	DT	O	3	NMOD
2	total	total	I-NP	JJ	O	3	NMOD
3	number	number	I-NP	NN	O	12	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	528	528	B-NP	CD	O	7	NMOD
6	diagnosed	diagnose	I-NP	VBN	O	7	NMOD
7	cases	case	I-NP	NNS	O	4	PMOD
8	with	with	B-PP	IN	O	3	NMOD
9	C.	C.	B-NP	NNP	O	11	NMOD
10	difficile	difficile	I-NP	JJ	O	11	NMOD
11	infection	infection	I-NP	NN	O	8	PMOD
12	were	be	B-VP	VBD	O	0	ROOT
13	identified	identify	I-VP	VBN	O	12	VC
14	.	.	O	.	O	12	P

1	Of	Of	B-PP	IN	O	6	VMOD
2	these	these	B-NP	DT	O	1	PMOD
3	,	,	O	,	O	6	P
4	twenty	twenty	B-NP	CD	O	5	NMOD
5	patients	patient	I-NP	NNS	O	6	SUB
6	underwent	undergo	B-VP	VBD	O	0	ROOT
7	colectomy	colectomy	B-NP	NN	O	6	OBJ
8	for	for	B-PP	IN	O	7	NMOD
9	FCDC	FCDC	B-NP	NN	B-cell_type	8	PMOD
10	(	(	O	(	O	13	DEP
11	3.7	3.7	B-NP	CD	O	12	NMOD
12	%	%	I-NP	NN	O	13	DEP
13	)	)	O	)	O	9	NMOD
14	.	.	O	.	O	6	P

1	All	All	B-NP	DT	O	2	NMOD
2	patients	patient	I-NP	NNS	O	3	SUB
3	had	have	B-VP	VBD	O	0	ROOT
4	received	receive	I-VP	VBN	O	5	NMOD
5	antibiotics	antibiotic	B-NP	NNS	O	3	OBJ
6	prior	prior	B-ADVP	RB	O	7	PMOD
7	to	to	B-PP	TO	O	3	VMOD
8	symptoms	symptom	B-NP	NNS	O	9	NMOD
9	development	development	I-NP	NN	O	7	PMOD
10	.	.	O	.	O	3	P

1	45	45	B-NP	CD	O	2	NMOD
2	%	%	I-NP	NN	O	5	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	patients	patient	B-NP	NNS	O	3	PMOD
5	had	have	B-VP	VBD	O	0	ROOT
6	multiple	multiple	B-NP	JJ	O	7	NMOD
7	antibiotics	antibiotic	I-NP	NNS	O	5	OBJ
8	.	.	O	.	O	5	P

1	35	35	B-NP	CD	O	2	NMOD
2	%	%	I-NP	NN	O	5	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	patients	patient	B-NP	NNS	O	3	PMOD
5	developed	develop	B-VP	VBD	O	0	ROOT
6	FCDC	FCDC	B-NP	NN	B-cell_type	5	OBJ
7	after	after	B-PP	IN	O	5	VMOD
8	having	have	B-VP	VBG	O	7	PMOD
9	three	three	B-NP	CD	O	10	NMOD
10	doses	dose	I-NP	NNS	O	8	OBJ
11	of	of	B-PP	IN	O	10	NMOD
12	prophylactic	prophylactic	B-NP	JJ	O	13	NMOD
13	antibiotic	antibiotic	I-NP	NN	O	11	PMOD
14	(	(	O	(	O	16	DEP
15	Cefuroxime	Cefuroxime	B-NP	NN	O	16	DEP
16	)	)	O	)	O	13	NMOD
17	for	for	B-PP	IN	O	8	VMOD
18	a	a	B-NP	DT	O	20	NMOD
19	surgical	surgical	I-NP	JJ	O	20	NMOD
20	procedure	procedure	I-NP	NN	O	17	PMOD
21	.	.	O	.	O	5	P

1	Time	Time	B-NP	NN	O	7	SUB
2	from	from	B-PP	IN	O	1	NMOD
3	referral	referral	B-ADJP	JJ	O	2	PMOD
4	to	to	B-PP	TO	O	2	PMOD
5	having	have	B-VP	VBG	O	4	PMOD
6	surgery	surgery	B-NP	NN	O	5	OBJ
7	varied	vary	B-VP	VBD	O	0	ROOT
8	.	.	O	.	O	7	P

1	Seventeen	Seventeen	B-NP	CD	O	2	NMOD
2	patients	patient	I-NP	NNS	O	3	SUB
3	received	receive	B-VP	VBD	O	0	ROOT
4	subtotal	subtotal	B-NP	JJ	O	8	NMOD
5	colectomy	colectomy	I-NP	NN	O	8	NMOD
6	and	and	I-NP	CC	O	8	NMOD
7	end	end	I-NP	NN	O	8	NMOD
8	ileostomy	ileostomy	I-NP	NN	O	3	OBJ
9	in	in	B-PP	IN	O	3	VMOD
10	a	a	B-NP	DT	O	12	NMOD
11	single	single	I-NP	JJ	O	12	NMOD
12	operation	operation	I-NP	NN	O	9	PMOD
13	.	.	O	.	O	3	P

1	Mortality	Mortality	B-NP	NN	O	2	NMOD
2	rate	rate	I-NP	NN	O	3	SUB
3	was	be	B-VP	VBD	O	0	ROOT
4	40	40	B-NP	CD	O	5	NMOD
5	%	%	I-NP	NN	O	3	PRD
6	.	.	O	.	O	3	P

1	Emergency	Emergency	B-NP	NN	O	2	NMOD
2	colectomy	colectomy	I-NP	NN	O	5	SUB
3	for	for	B-PP	IN	O	2	NMOD
4	FCDC	FCDC	B-NP	NN	B-protein	3	PMOD
5	is	be	B-VP	VBZ	O	0	ROOT
6	associated	associate	I-VP	VBN	O	5	VC
7	with	with	B-PP	IN	O	6	VMOD
8	high	high	B-NP	JJ	O	10	NMOD
9	mortality	mortality	I-NP	NN	O	10	NMOD
10	rate	rate	I-NP	NN	O	7	PMOD
11	.	.	O	.	O	5	P

1	The	The	B-NP	DT	O	2	NMOD
2	majority	majority	I-NP	NN	O	13	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	patients	patient	B-NP	NNS	O	3	PMOD
5	who	who	B-NP	WP	O	4	NMOD
6	have	have	B-VP	VBP	O	5	SBAR
7	significant	significant	B-NP	JJ	O	8	NMOD
8	co-morbidities	co-morbidity	I-NP	NNS	O	6	OBJ
9	(	(	O	(	O	12	DEP
10	75	75	B-NP	CD	O	11	NMOD
11	%	%	I-NP	NN	O	12	DEP
12	)	)	O	)	O	4	NMOD
13	did	do	B-VP	VBD	O	0	ROOT
14	not	not	I-VP	RB	O	13	VMOD
15	survive	survive	I-VP	VB	O	13	VC
16	following	follow	B-PP	VBG	O	15	VMOD
17	emergency	emergency	B-NP	NN	O	18	NMOD
18	colectomy	colectomy	I-NP	NN	O	16	PMOD
19	.	.	O	.	O	13	P

1	Therefore	Therefore	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	it	it	B-NP	PRP	O	4	SUB
4	is	be	B-VP	VBZ	O	0	ROOT
5	crucial	crucial	B-ADJP	JJ	O	4	PRD
6	to	to	B-VP	TO	O	7	VMOD
7	identify	identify	I-VP	VB	O	5	AMOD
8	those	those	B-NP	DT	O	9	NMOD
9	patients	patient	I-NP	NNS	O	7	OBJ
10	early	early	B-ADVP	RB	O	7	VMOD
11	in	in	B-PP	IN	O	7	VMOD
12	their	their	B-NP	PRP$	O	14	NMOD
13	disease	disease	I-NP	NN	O	14	NMOD
14	course	course	I-NP	NN	O	11	PMOD
15	before	before	B-SBAR	IN	O	7	VMOD
16	they	they	B-NP	PRP	O	17	SUB
17	progress	progress	B-VP	VBP	O	15	SBAR
18	into	into	B-PP	IN	O	17	VMOD
19	FCDC	FCDC	B-NP	NN	B-cell_type	22	NMOD
20	and	and	I-NP	CC	O	22	NMOD
21	organ	organ	I-NP	NN	O	22	NMOD
22	failure	failure	I-NP	NN	O	18	PMOD
23	.	.	O	.	O	4	P

